
Hims & Hers drops plan to copy Wegovy weight‑loss drug
Hims & Hers has canceled its plan to develop a Wegovy‑style weight‑loss medication, shelving a project to mimic Novo Nordisk’s semaglutide as the company reassesses its drug‑development strategy in the competitive obesity market.













